Nanoparticulate carrier mediated intranasal delivery of insulin for the restoration of memory signaling in alzheimer's disease

Current Nanoscience

Volumn 9, Issue 1, 2013, Pages 46-55

  Dwivedi, Pankaj ^a   Tekade, Rakesh Kumar ^b,c   Jain, Narendra Kumar ^c  

^a CIPLA LTD   (India)

^b DR H S GOUR UNIVERSITY   (India)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Alzheimer; Biodistribution study; Co polymer nanoparticle; Insulin; Restoration of memory signaling

Indexed keywords

CHITOSAN; CONTROLLED DRUG DELIVERY; EMULSIFICATION; GLUCOSE; INSULIN; MASS SPECTROMETRY; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PLASTIC COATINGS; RESTORATION; TARGETED DRUG DELIVERY;

ALZHEIMER; ALZHEIMER'S DISEASE; BIODISTRIBUTIONS; BLOOD GLUCOSE LEVEL; DOUBLE EMULSIFICATIONS; PEGYLATED NANOPARTICLE; PERIPHERAL REGIONS; THERAPEUTIC POTENTIALS;

SIGNAL RECONSTRUCTION;

CHITOSAN; GLUCOSE; INSULIN; NANOPARTICLE; POLYSORBATE 20; POLYSORBATE 80; POLYVINYL ALCOHOL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; GLUCOSE BLOOD LEVEL; HEMOLYSIS; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

EID: 84875926133     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/1573413711309010010     Document Type: Article

References (36)

1. Barratt, G.M. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol, 2000, 3, 163-171.
2. Schmidt, S.D.; Nixon, R.A.; Mathews, P.M. Tissue processing prior to analysis of Alzheimer's disease associated proteins and metabolites, including aβ. Methods Mol Biol, 2012, 849, 493-506.
3. Tekade, R. K.; Vijayarajkumar, P.; Jain, N. K. Dendrimers in oncology: An expanding horizon. Chem. Rev., 2009, 109, 49-87.
4. Belesti, A.; Leontiadis, L.; Klepetsanis, P.; Ithakissios, D.S.; Avgoustakis, K. Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide)-methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery. Int. J. Pharm., 1999, 182, 187-197.
5. Chien, Y.W.; Su K.S.E.; Chang S.F. Nasal systemic drug delivery. New York, Marcel Dekker, Inc., 1989; pp 229-268.
6. Craft, S.; Newcomer, J.; Kanne, S.; Jack, D.S.; Cryer, P.; Sheline, Y.; Luby, J.; Jack, D. A.; Alderson, A. Memory improvement following induced hyper-insulinemia in alzheimer's disease. Neurobiol Aging, 1996, 17, 123-130.
7. Davda, J.; Labhasetwar, V. Characterization of nanoparticle uptake by endo- thelial cells. Int. J. Pharm., 2002, 223, 51-59.
8. Fisher, R.S. Ho, J. Potential New Methods for Antiepileptic Drug Delivery.CNS Drugs., 2002, 16, 579-593.
9. Fry, E.; Acharya, R.; Stuart, D. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem., 1978, 90, 809-815.
10. Gardman, J.G.; Limbird, L.E. Goodman and Gilman's: The Pharmacological basis of therapeutics, 11 edition, Mc Graw Hill, 2008; pp 1679-1701.
11. Shahnaz, G.; Vetter, A.; Barthelmes, J.; Rahmat, D.; Laffleur, F.; Iqbal, J.; Perera, G.; Schlocker, W.; Dünnhaput, S.; Augustijns, P, Bernkop-Schnurch, A. Thiolated chitosan nanoparticles for the nasal administration of leuprol- ide: Bioavailability and pharmacokinetic characterization. Int J Pharm., 2012, 30, 164-170.
12. Illum, L. Is nose-to-brain transport of drugs in man a reality? J. Pharm. Pharmacol, 2004, 56, 3-17.
13. Kreuter, J. Nanoparticles, in Colloidal Drug Delivery Systems, J.Kreuter, Editor. Marcel Dekker: New York, 1994; pp 219- 342.
14. Kreuterr, J. Nanoparticles, in Encyclopaedia of Pharmaceutical Technology, Swarbrick J, Editor. Marcel Dekker Inc.: New York, USA 1994; pp 165-190.
15. Li, Y.P.; Ying Pei, Y.; Zhang, X.Y.; Gu, Z.H.; Zhou, Z.H.; Yuan, W.F.; Zhou, J.J.; Zhu, J.H.; Gao, X.J. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control Release, 2001, 71, 203-211.
16. Wang, Y.; Gou, M.; Gong, C.; Wang, C.; Qian, Z.; Lin, Y.F.; Luo, F. Phar-macokinetics and Disposition of Nanomedicine Using Biodegradable PEG/PCL Polymers as Drug Carriers. Curr Drug Metab., 2012, 1, 338-353.
17. Lockman, P.R.; Mumper, R.J.; Khan, M.A.; Allen, D.D. Nanoparticle technology for drug delivery across the blood-brain barrier, Drug Dev. Ind. Pharm., 2002, 1-13.
18. Mathison, S.; Nagilla, R. Kompella, U. B. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction. J. Drug Target., 1998, 5, 415-441.
19. Morrison, E.E.; Costanzo, R.M. Morphology of the human olfactory epithelium. J. Compa. Neurol., 1992, 297, 1-13.
20. Mygind, N.; Pedersen, M.; Nielsen, M.H. Morphology of the upper airway epithelium. In: Andersen, D.F.P.A.I. (Ed.) Elsevier, Amsterdam: 1982; pp 71-91.
21. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev., 2003, 55, 329-347.
22. Pitt, C.G.; Chasalow, F.I.; Hibionada, Y.M.; Klimas, D.M.; Schindler, A. Aliphatic polyesters. I. The degradation of Poly(-caprolactone) in vivo. J. Appl. Polym. Sci., 1983, 28, 3779-3787.
23. Proctor, F. Clearance of Inhaled Particles from the Human Nose Arch. Int. Med., 1973, 131, 132-139.
24. Rakel, P. Conn's Current Therapy. 57th ed. Philadelphia, Pa: Saunders; 2005; pp 30-49
25. Redhead, H.M.; Davis, S.S.; Illum, L. Drug delivery in poly(lactide-coglycolide) nanoparticles surface modifi ed with poloxamer 407 and polox-amine 9028: in vitro characterisation and in vivo evaluation. J. Control. Release, 2001, 70, 353-363.
26. Shubert, M.A.; Mullar, C.C. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm., 2005, 61, 77-86.
27. Tekade, R. K.; Dutta, T.; Tyagi, A.; Bharti, A. C.; Das, B. C.; Jain, N. K. Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy. J. Drug Target., 2008, 16(10), 758-772.
28. Talegoankar, S.; Mishra, P.R. Intranasal delivery: An approach to bypass the blood brain barrier. Ind. J. Pharmacol., 2004, 36, 140-147.
29. Thorne, R.G.; Pronk, G.J.; Padmanabhan, V.; Frey, W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neurosciences, 2004, 127, 481-496.
30. Senthil RD, Gowda KV, Mendal U, Ganesan M, Bose A, Sarkar AK, Pal TK. Development of RP-HPLC for analysis of human insulin. Bioequivalance Study Center, Jadhavpur University, Kolkata, 2006 (68) 662-665.
31. Kona S, Specht D, Rahimi M, Shah BP, Gilbertson TA, Nguyen KT. Targeted biodegradable nanoparticles for drug delivery to smooth muscle cells. J Nanosci Nanotechnol., 2012, 12, 236-244.
32. Vanrell, R.H.; Rincon, A.C.; Alonso, M.; Reboto, V.; Molina-Martnez, I.T. Rodriguez-Cabello, J.C. Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J. Control. Release, 2005, 102, 113-122.
33. Wei, G.; Wang, D.; Lu, H.; Parmentier, S.; Wang, Q.; Panter, S. S.; Frey, W.H.; Ying, W. Intranasal administration of a PARG inhibitor profoundly decreases ischemic brain injury. Front. Biosci., 2007, 12, 4986-4996.
34. Ying, W.; Wei, G.; Wang, D.; Wang, Q.; Tang, X.; Shi, J.; Zhang, P.; Lu, H. Intranasal administration with NAD profoundly decreases brain injury in a rat model of transient focal ischemia. Front. Biosci., 2007, 12, 2728-2734.
35. Tekade, R.K.; Dutta, T.; Gajbhiye, V.; Jain, N.K. Exploring Dendrimers towards Dual-Drug Delivery: pH Responsive Simultaneous Kinetics. J. Mi-croencapsulation, 2009, 26, 287-296.
36. Onishi, H.; Machida, Y. In vitro and In vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs. Mol. Rev., 2008, 13, 2136-2155.